Insilico Medicine, Biopharmaceuticals Strike: AI Drug Deal Heads Toward $2.5B
Insilico Medicine and SK Biopharmaceuticals unveiled a milestone collaboration worth up to $2.5 billion to develop ne...
A comprehensive zero based budget checklist can help you stay on track. Use it to ensure you don’t miss any budgeting steps.
17,508 articlesInsilico Medicine and SK Biopharmaceuticals unveiled a milestone collaboration worth up to $2.5 billion to develop ne...
Strobe Finance, the XRP Ledger EVM Sidechain’s sole native lending protocol, is winding down. Users must repay loans ...
Micron Technology rides the AI memory wave, but a blowout earnings report invites questions. This guide breaks down t...
AMLP delivered a record May 2026 payout and a 14% trailing return, underscoring resilient midstream cash flow. Invest...
Tenable has bumped higher again, fueled by fresh analyst optimism and stronger demand for cybersecurity tools. This g...
A seven-year high in regional bank M&A signals bigger players aiming for scale and efficiency. This guide breaks down...
The AI boom has cooled, but the backbone of AI—data centers and cloud services—remains essential. This guide highligh...
ANSEM surged 299% over the past week, reviving momentum in Solana's memecoin scene and lifting overall ecosystem acti...
As earnings season unfolds, Apogee faces a meaningful year ahead. This article breaks down Q1 signals, outlines a rea...
Are patient investors finally getting a chance to weigh SpaceX as a long-term growth play? This guide explains how a ...
The memory market is showing persistent strength, and SK Hynix sits at the center of the narrative. This article expl...
Semiconductors retreat while Apple climbs, creating an unusual market dynamic. This article breaks down what the chip...